Boston Therapeutics Cash Flow - Annual (OTCBB:BTHE)

Add to My Stocks
$0.04 $0.01 (20%) BTHE stock closing price Sep 18, 2018 (Closing)

For analyzing any company like Boston Therapeutics from an investment perspective, its important to check the cash flow statement. Financials statements like the Boston Therapeutics income statement and Boston Therapeutics balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Boston Therapeutics had cash and cash equivalents of $- at beginning of the year and $- at year end for 2017. Boston Therapeutics cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Boston Therapeutics has a negative cash and cash equivalents change of $-0.54M.

View details of Boston Therapeutics cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012201120102009
Net Income Cash Flow
-1.58M-3.73M-2.48M-4.69M-4.6M-1.48M-0.82M-0.24M-
Depreciation Depletion Amortization Cash-Flow1.57M1.09M-------
Net Increase (Decrease) in Assets Liabilities------0.04M---
Cash From (used in) Discontinued Operations---------
Other Adjustments Net-1.36M1.2M--2.06M----
Net Cash from (used by) Operating Activities
-1.27M-1.24M-1.29M-3.47M-2.33M-0.85M-0.39M-0.11M-
Increase (Decrease) in Prop Plant And Equipment----0.01M-0.01M-0.01M---
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
----0.01M-0.01M-0.01M---
Issuance (Purchase) of Equity Shares----5.18M1.14M---
Issuance (Repayment) of Debt Securities-2.15M-------
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities--0.25M-------
Net Cash from (used by) Financing Activities
-1.89M1.17M-5.18M1.18M---
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
-0.54M--0.11M-3.23M2.83M---0.01M-
Cash & Equivalents at Beginning of Year---3.38M-----
Cash & Equivalents at Year End----3.38M----
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Lexicon Pharma financial analysis

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Boston Therapeutics stock price history and Boston Therapeutics stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Boston Therapeutics is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Boston Therapeutics stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-1.27M for BTHE.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for BTHE stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $- for Boston Therapeutics. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Boston Therapeutics Cash Flow

Annual Cash Flow Statements For Boston Therapeutics Inc Peers

Biostar Pharma cash flow, Integrated Biopharma cash flow, Lexicon Pharma cash flow